Instadose Pharma (INSD) Price & Analysis

18 Followers

INSD Stock Chart & Stats

<$0.01

$0.00(0.00%)

At close: Jul 30 4:00 PM EDT

<$0.01

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.24 - $0.25

Previous CloseN/A

Volume200.00

Average Volume (3M)N/A

Market Cap

$532.00

Enterprise Value$53.19K

Total Cash (Recent Filing)$5.33K

Total Debt (Recent Filing)$237.52K

Price to Earnings (P/E)―

Beta-55.94

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding531,933,800

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio-2.09

Price to Book (P/B)-14.53K

Price to Sales (P/S)0.00

P/FCF Ratio-22.29M

Enterprise Value/Market Cap99.99

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit-0.11

Enterprise Value/Ebitda-0.05

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

INSD FAQ

What was Instadose Pharma’s price range in the past 12 months?

Instadose Pharma lowest stock price was $0.24 and its highest was $0.25 in the past 12 months.

What is Instadose Pharma’s market cap?

Instadose Pharma’s market cap is $532.00.

When is Instadose Pharma’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Instadose Pharma’s earnings last quarter?

Currently, no data Available

Is Instadose Pharma overvalued?

According to Wall Street analysts Instadose Pharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Instadose Pharma pay dividends?

Instadose Pharma does not currently pay dividends.

What is Instadose Pharma’s EPS estimate?

Instadose Pharma’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Instadose Pharma have?

Instadose Pharma has 531,933,800 shares outstanding.

What happened to Instadose Pharma’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Instadose Pharma?

Currently, no hedge funds are holding shares in INSD

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Instadose Pharma

Founded in 2017 and based in Burlington, Canada, Instadose Pharma Corp. specializes in the international cultivation, processing, and distribution of pharmaceutical-grade cannabinoid oil.